Compare Aptus Pharma with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
INR 235 Cr (Micro Cap)
81.00
32
0.00%
-0.28
13.64%
10.83
Total Returns (Price + Dividend) 
Aptus Pharma for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Board Meeting Outcome for Outcome Of Board Meeting Held On March 24 2026
24-Mar-2026 | Source : BSEOutcome of Board Meeting held on March 24 2026
Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Tuesday March 24 2026
17-Mar-2026 | Source : BSEAptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/03/2026 inter alia to consider and approve This is to inform you that meeting of the Board of Directors of the Company will be held on Tuesday March 24 2026 at Shri 1st Floor Opp Satyasai Heart Hospital Narayan Nagar Kalawad Road Kankot Rajkot Gujarat India 360005 to consider inter alia a proposal for: 1. Increase in Authorized Share Capital subject to approval of members of the Company. 2. Consideration and recommendation of Bonus Equity Shares subject to approval of Members of the Company. Trading Window for dealing in the securities of the Company for all the Designated Persons and their immediate relatives will remain closed with effect from Wednesday 18th March 2026 Thursday March 26 2026 (both days inclusive) for aforesaid consideration/recommendation of the Board of Directors of the Company.
Closure of Trading Window
17-Mar-2026 | Source : BSEWith Reference to the above mentioned subject it is hereby informed that the trading window for dealing in shares of Aptus Pharma Limited for all designated persons will remain closed from Wednesday March 18 2026 to Thursday March 26 2026 (both days inclusive) for the purpose of 1. Increase in Authorized Share Capital subject to the approval of Members and 2. Consideration and recommendation of Bonus issue of equity shares subject to aproval of Members.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Kapilbhai Hasmukhbhai Chandarana (11.3%)
Saint Capital Fund (4.29%)
22.97%






